<--- Back to Details
First PageDocument Content
Health / Division of Acquired Immunodeficiency Syndrome / HIV vaccine / HIV Vaccine Trials Network / Influenza vaccine / National Institute of Allergy and Infectious Diseases / Malaria vaccine / Barton Haynes / Modified vaccinia Ankara / Vaccines / Vaccination / Medicine
Date: 2012-11-01 09:29:53
Health
Division of Acquired Immunodeficiency Syndrome
HIV vaccine
HIV Vaccine Trials Network
Influenza vaccine
National Institute of Allergy and Infectious Diseases
Malaria vaccine
Barton Haynes
Modified vaccinia Ankara
Vaccines
Vaccination
Medicine

Vaccine Research and Development, NIAID Profile FY 2003

Add to Reading List

Source URL: www.niaid.nih.gov

Download Document from Source Website

File Size: 142,79 KB

Share Document on Facebook

Similar Documents

Tuberculosis / Vaccine / JN-International Medical Corporation / Division of Acquired Immunodeficiency Syndrome

BIO-INNOVATION Health Innovation Innovation for health includes the development of new drugs, vaccines,

DocID: 1p3DX - View Document

HIV/AIDS / Microbiology / Health / Medicine / HIV vaccine / Tat / HIV / Virus / Division of Acquired Immunodeficiency Syndrome / HIV/AIDS research

Department of Biomathematics Seminar Series: Frontiers in Systems and Integrative Biology Theoretical Approaches towards HIV Vaccine Designs and Incidence Assessment

DocID: 1kYh1 - View Document

HIV / Virus / AIDS / Division of Acquired Immunodeficiency Syndrome / Antiviral drug / HIV/AIDS / Health / Medicine

EMBARGOED UNTIL Tuesday, April 29, :15 p.m. PDT MEDIA CONTACTS BELOW

DocID: 1aAsg - View Document

HIV / Microbiology / HIV/AIDS in China / Division of Acquired Immunodeficiency Syndrome / HIV/AIDS / Health / Medicine

color adslicksindd

DocID: 1a1MN - View Document

Long-term nonprogressor / Millennium Development Goals / HIV / AIDS / Zidovudine / Antiviral drug / HIV vaccine / Division of Acquired Immunodeficiency Syndrome / HIV/AIDS / Medicine / Health

PRESS RELEASE Under embargo till July 20, 9 a.m. EST Washington, D.C., July 20, A new initiative, the Collaboration for HIV/AIDS Immunological Therapy (CHAIT), will be announced at the HIV Functional Cure Symposi

DocID: 19Ru5 - View Document